Vinge advises Kafrit Industries (1993) Ltd on acquisition of Addvanze AB.

Kafrit Industries (1993) Ltd is an innovative and world leading producer of customized Masterbatches and Compounds for the plastic industry. For over 40 years Kafrit and its subsidiaries have been selling unique products and giving added value to well known customers around the world. Addvanze AB is a leading producer of the masterbatch in Europe.

Vinge’s team consisted of, among others, partners Christina Kokko and Matthias Pannier and associates Isabelle Jengsell and Amanda Steen (M&A), Isabell Nielsen (Agreements), Ludvig Wettergren and Karl-Gustaw Tobola (Banking and finance), Sara Strandberg (Employment), Sofia Bergenstråhle (IPR), Karl-Hugo Engdahl (IT/GDPR), Lina Österberg (Real Estate and environment) and VDR assistant Nathalie Hughes.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised EQT managed Scaleup Europe Fund on its investment in Tandem Health

Vinge has advised EQT managed Scaleup Europe Fund as lead investor in Tandem Health's USD 100 million Series B investment round, with participation from existing investors Kinnevik, Northzone, Amino Collective and Visionaries. Tandem Health is an AI healthcare company founded in 2023 and headquartered in Sweden. Tandem Health operates as an AI partner within the healthcare sector across Europe, providing AI medical assistant support to clinicians in connection with patient visits.
September 15, 2026